Clinical Study to Evaluate the Safety and Anti-Tumor Activity of AB-201
NCT07333820
·
clinicaltrials.gov ↗
PHASE1
Phase
NOT_YET_RECRUITING
Status
18
Enrollment
OTHER
Sponsor class
Conditions
Malignant Neoplasm of Stomach, Unspecified
Interventions
DRUG:
AB-201 Dose escalation
Sponsor
Yonsei University